Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease

Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy

(2010) P de Graaf et al.   BRITISH JOURNAL OF PHARMACOLOGY

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

(2010) B. Jharap et al.   INFLAMMATORY BOWEL DISEASES

Limited Intra-Individual Variability in Hypoxanthine-Guanine Phosphoribosyl Transferase, Thiopurine S-Methyl Transferase, and Xanthine Oxidase Activity in Inflammatory Bowel Disease Patients During 6-Thioguanine Therapy

(2010) D. P. van Asseldonk et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome

(2009) Jayshri A. Shah et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

(2008) G Stocco et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations

(2007) Sofie Haglund et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY